EMA advises about risks of using weight loss medicine Mysimba with opioids
26/07/2024
Leggi
Association of semaglutide with tobacco use disorder in patients with type 2 diabetes: target trial emulation using real-world data
Wang W, Volkow ND, Berger NA, et al.
Ann Intern Med. Pub. online 30 Jul 2024.
Leggi
FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products
26/07/2024
Leggi
MiniMed 780G system use in type 1 diabetes during Ramadan intermittent fasting: a systematic literature review and expert recommendations
Elbarbary NS, Alguwaihes A, Zarif H, et al.
Diabetes Technol Ther. Pub. online 25 Jul 2024.
Leggi
Body weight change associated kidney outcomes of sodium-glucose cotransporter new users
Jimba T, Kaneko H, Azegami T, et al.
Diabetes Obes Metab. Pub. online 28 Jul 2024.
Leggi
Frequency of rebound hyperglycemia in adults with type 1 diabetes treated with different insulin delivery modalities
Tidemand KG, Laugesen C, Ranjan A, et al.
Diabetes Technol Ther. Pub. online 25 Jul 2024.
Leggi
Follow-up and monitoring programme in children identified in early-stage type 1 diabetes during screening in the general population of Italy
Cherubini V, Mozzillo E, Iafusco D, et al.
Diabetes Obes Metab. Pub. online 26 Jul 2024.
Leggi
Health care expenditure among US adults with heart failure with and without diabetes
Shah CH, Fonarow GC, Echouffo-Tcheugui JB
Am J Cardiol. Pub. online 24 Jul 2024.
Leggi
Association of PCSK9 inhibitors with mortality: insights from a retrospective cohort analysis
Huang CH, Wang SI, Fan FS, et al.
Eur Heart J Cardiovasc Pharmacother. Pub. online 25 Jul 2024.
Leggi
NUOVA SURVEY AMD – DISLIPIDEMIE E RISCHIO CARDIOVASCOLARE
Carissimi Soci, desideriamo condividere una breve indagine conoscitiva incentrata sulla Gestione della terapia ipolipemizzante nella persona con diabete e ipercolesterolemia o dislipidemia a rischio CV alto e molto alto. Un tema di grande attualità per la diabetologia e, grazie alla vostra esperienza e testimonianza, potremo programmare prossime iniziative formative in…
Leggi